Home Your basket
• Auditory screening in neo...
   Price 8.50 €
• Comparison of stapes prot...
   Price 15.00 €
• Carcinogenesis of the eth...
   Price 10.50 €
• Schwannoma of the tongue:...
   Price 5.50 €
• Bilateral vestibular loss...
   Price 10.50 €
• Comparative study using A...
   Price 10.50 €
• Frontal sinus osteoma and...
   Price 5.50 €
• Interventional phoniatry...
   Price 14.00 €
• Prospective evaluation of...
   Price 10.50 €
• Usefulness and limitation...
   Price 10.50 €
• A case of nasal NK/T cell...
   Price 5.50 €
• The symphonix symposium u...
   Price 8.50 €
• Hearing preservation in p...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Respiratory epithelial ad...
   Price 12.50 €
• Cowden syndrome: Otolaryn...
   Price 12.00 €
• Bilateral cleft lip and c...
   Price 14.00 €
• Laryngeal schwannoma: A c...
   Price 8.50 €
• Surgical treatement by in...
   Price 12.50 €
• Social consequence of a d...
   Price 10.50 €
• Vertigo and pathology of ...
   Price 10.50 €
• Congenital anomalies of n...
   Price 14.00 €
• A remnant tooth in an ede...
   Price 8.50 €
• Merkel cell carcinoma of ...
   Price 8.50 €
• Guidelines for the clinic...
   Price 12.50 €
• Synovial sarcoma of the h...
   Price 5.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Laryngeal schwannoma: A c...
   Price 5.50 €
• Chronic laryngitis...
   Price 8.50 €
• Rhinoplasty: Advantages a...
   Price 10.50 €
• Disability in patients wi...
   Price 10.50 €
• Transsexuality: Speech th...
   Price 10.50 €

Total Order 319.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2007 o

ONCOLOGY

Acute mesenteric ischemia and rhinopharyngeal carcinoma


Authors : Pigneret S, Baudon Lecame M, Chédru Legros V, Choussy O, Babin E. (Caen, Rouen)

Ref. : Rev Laryngol Otol Rhinol. 2007;128,2:105-108.

Article published in french
Downloadable PDF document french



Summary : This work is a part of a pharmacovigilancy survey. Objectives: To determine the links between radiation therapy, chemotherapy, nasopharyngeal carcinoma and mesenteric ischemia. Material and methods: A case of 69 year old man with a nasopharyngeal carcinoma, treated by radiation therapy and chemotherapy, who developed a lethal mesenteric ischemia is described. Etiology of mesenteric ischemia was unknown. A review of literature had been made on Pubmed® with terms: «mesenteric ischemia» and cisplatin, 5-FU or fluorouracil, radiation therapy, cancer or neoplasm, «head and neck cancer» or «carcinoma of the nasopharynx». Results: In our case, the origin of the mesenteric ischemia is not atheromatous. Chimiotherapy with 5-fluorouracile and cisplatine, radiation therapy and morphine were suspected. According to literature, responsibility of morphine and radiation therapy is uncertain. In opposition, the 5-FU and the cisplatine can be incriminated. Conclusion: Mesenteric ischemia is an uncommon adverse effect of a treatment with cisplatin and 5-FU. It’s the second case of mesenteric ischemia associated with a treatment with 5-FU and cisplatin in a patient with a nasopharyngeal carcinoma. ENT physicians must be aware of this complication.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE